Combinatorial Targeting of Avapritinib-Driven MAP Kinase Activation in High-Grade Glioma.
Schwark K, Wink K, De Cola A, Miclea M, Patel T, Kong S, Stanczak A, Doherty R, Pearson A, Murthy B, Lau B, Cartaxo RT, Messinger D, Ji S, Wadden J, Clausen M, de la Nava D, Goethe P, Momen F, Adam T, Hutchinson A, Niculcea M, Serhan H, Merrill NM, Edmonds A, Mayr L, Neyazi S, Muñoz DP, Hwang Y, Nuechterlein NK, Fernández EC, Califano A, Pavisic J, Garton H, Rao R, Upadhyaya SA, Skrypek M, Bendel AE, Lobbous M, Klawinski D, Merajver SD, Koptyra MP, Resnick AC, Nazarian J, Venneti S, Waszak SM, Chavez L, Gojo J, Filbin MG, Beck A, Pathania M, Coppe JF, Koschmann C.
Schwark K, et al. Among authors: chavez l.
Res Sq [Preprint]. 2026 Jun 24:rs.3.rs-9974885. doi: 10.21203/rs.3.rs-9974885/v1.
Res Sq. 2026.
PMID: 42396537
Free PMC article.
Preprint.